Bluejay Investor Presentation Deck

Financial Highlights Financial Info (March 31, 2023) Cash* Est. Cash Runway Clean Balance Sheet BJDX (NASDAQ) (June 1, 2023) Market Cap Average Daily Trading Volume (30 day) Shares Outstanding DIAGNOSTICS $6.8 M < 12 months No outstanding warrants or debt $4.6M 313K shares 20.5M The Symphony™ System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA Symphony Symphony L Symphony Symphony f yo Erbacity Sympheny 000 Kelanta Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | June 2023 14

View entire presentation